Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Blood
|
March 28, 2012
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
Aida Inbal, Johannes Oldenburg, Manuel Carcao, et al.
Blood Reviews
|
June 16, 2015
The use of recombinant activated factor VII in patients with acquired haemophilia
Andreas Tiede, Kagehiro Amano, Alice Ma, et al.
Blood Reviews
|
June 16, 2015
Safety update on the use of recombinant activated factor VII in approved indications
Ellis J Neufeld, Claude Négrier, Per Arkhammar, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
February 22, 2005
Influence of image-capturing parameters on digital X-ray radiogrammetry
Joachim Böttcher, Alexander Pfeil, Anders Rosholm, et al.
Investigative Radiology
|
December 16, 2005
Computerized quantification of joint space narrowing and periarticular demineralization in patients with rheumatoid arthritis based on digital x-ray radiogrammetry
Joachim Böttcher, Alexander Pfeil, Anders Rosholm, et al.
Thrombosis and Haemostasis
|
February 16, 2018
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency
Manuel Carcao, Carmen Altisent, Giancarlo Castaman, et al.
Journal of Digital Imaging
|
April 22, 2006
Computerized digital imaging techniques provided by digital X-ray radiogrammetry as new diagnostic tool in rheumatoid arthritis
Joachim Böttcher, Alexander Pfeil, Anders Rosholm, et al.
Journal for Immunotherapy of Cancer
|
January 8, 2025
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study
Peter Hillemanns, Michal Zikan, Frédéric Forget, et al.
The Lancet. Neurology
|
September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Blood
|
March 28, 2012
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
Aida Inbal, Johannes Oldenburg, Manuel Carcao, et al.
Blood Reviews
|
June 16, 2015
The use of recombinant activated factor VII in patients with acquired haemophilia
Andreas Tiede, Kagehiro Amano, Alice Ma, et al.
Blood Reviews
|
June 16, 2015
Safety update on the use of recombinant activated factor VII in approved indications
Ellis J Neufeld, Claude Négrier, Per Arkhammar, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
February 22, 2005
Influence of image-capturing parameters on digital X-ray radiogrammetry
Joachim Böttcher, Alexander Pfeil, Anders Rosholm, et al.
Investigative Radiology
|
December 16, 2005
Computerized quantification of joint space narrowing and periarticular demineralization in patients with rheumatoid arthritis based on digital x-ray radiogrammetry
Joachim Böttcher, Alexander Pfeil, Anders Rosholm, et al.
Thrombosis and Haemostasis
|
February 16, 2018
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency
Manuel Carcao, Carmen Altisent, Giancarlo Castaman, et al.
Journal of Digital Imaging
|
April 22, 2006
Computerized digital imaging techniques provided by digital X-ray radiogrammetry as new diagnostic tool in rheumatoid arthritis
Joachim Böttcher, Alexander Pfeil, Anders Rosholm, et al.
Journal for Immunotherapy of Cancer
|
January 8, 2025
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study
Peter Hillemanns, Michal Zikan, Frédéric Forget, et al.
The Lancet. Neurology
|
September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Page
of 1